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Cells under stress activate cell survival and cell death signaling pathways. Cell death
signaling frequently converges on mitochondria, a process that is controlled by the
activities of pro- and anti-apoptotic B-cell lymphoma 2 (BCL-2) proteins. In this review,
we summarize current knowledge on the control of neuronal survival, development and
injury by anti-apoptotic BCL-2 family proteins. We discuss overlapping and differential
effects of the individual family members BCL-2, BCL-extra long (BCL-XL), myeloid cell
leukemia 1 (MCL-1), and BCL2-like 2 (BCL-W) in the control of survival during development
and pathophysiological processes such as trophic factor withdrawal, ischemic injury,
excitotoxicity, oxidative stress and energy stress. Finally we discuss recent evidence that
several anti-apoptotic BCL-2 proteins influence mitochondrial bioenergetics and control
neuronal Ca2+ homeostasis independent of their classical role in cell death signaling.
Keywords: BCL-2, apoptosis, mitochondria, neuronal injury, neuronal development, neurodegeneration, ischemia,
excitotoxcity
THE BCL-2 PROTEIN FAMILY
The BCL-2 gene was first identified in B-cell follicular lymphomas
(Tsujimoto et al., 1985). The BCL-2 protein family act as key regu-
lators in the intrinsic or “mitochondrial” apoptosis pathway. The
different BCL-2 protein family either trigger or constrain apop-
tosis (Youle and Strasser, 2008). They are classified into three
different classes depending on their structural and functional
properties: (a) anti-apoptotic BCL-2 proteins including BCL-
2 itself, BCL-XL (BCL-extra long), MCL-1 and BCL-W which
contain four BH(1-4) domains (Czabotar et al., 2014); (b) pro
pro-apoptotic proteins BAX (BCL-2-associated × protein), BAK
(BCL-2-antagonist/killer-1) (Wei et al., 2001) and potentially
BOK (BCL-2 related ovarian killer) that contain three conserved
BH domains and interacts strongly with some anti-apoptotic pro-
teins (Hsu et al., 1997); and (c) BH3-only proteins including BIM
(BCL-2 interacting mediator), PUMA (p53 upregulated modula-
tor of apoptosis), BID (BH3 interacting domain death agonist),
BIK (BCL-2 interacting killer), BAD (BCL-2 associated death
promoter), BMF (BCL-2 modifying factor, Hrk (Hara-kiri) and
NOXA (Latin for “damage”) that have homology to the BCL-2
family proteins in only a single domain, the BH3 domain (Giam
et al., 2008; Happo et al., 2012). While anti-apoptotic BCL-2
family proteins as well as BAX and BAK are often constitutively
expressed in cells, BH3-Only proteins are typically transcrip-
tionally or post-translationally activated in response to apoptotic
stress signaling (Engel et al., 2011). Activation of the mitochon-
drial apoptosis pathway through pro-apoptotic BCL-2 proteins
is able to activate different cell death pathways including apop-
tosis (Kilbride and Prehn, 2013). The key upstream event that
leads to the activation of these different pathways is mitochon-
drial outer membrane permeabilization (MOMP). This process
is triggered by the membrane insertion and oligomerization of
the pro-apoptotic members BAX and BAK, with subsequent
release of apoptosis-activating factors such as cytochrome c (cyt c)
from the mitochondrial intermembrane space to the cytosol. Two
models have been proposed for the activation of BAX and BAK
during apoptosis: (a) the direct activation model where BAX and
BAK activation occurs directly through conformational changes
induced by BH3-only proteins (Letai et al., 2002) and (b) indirect
activation model where cell death signals induce the binding of
BH3-only pro-apoptotic initiators to anti-apoptotic BCL-2 pro-
teins, facilitating the release and activation of BAX and BAK
(Uren et al., 2007; Willis et al., 2007). Anti-apoptotic BCL-2 pro-
teins are integral membrane proteins, possessing a C-terminal
transmembrane domain that localizes these proteins to intracel-
lular membranes, notably the mitochondrial outer membrane
(MOM), but also the endoplasmic reticulum and the nuclear
envelope (Cory and Adams, 2002; Chipuk et al., 2006; Brunelle
and Letai, 2009; Tait and Green, 2010) and where they are also
able to inhibit the process of MOMP by binding to pro-apoptotic
BCL-2 proteins (Gonzalez-Garcia et al., 1994; Yang et al., 1995,
1997).
ACUTE NEURONAL INJURY AND BCL-2 PROTEINS
Neurons are highly specialized, excitable cells that communi-
cate to other target neurons through the process of synaptic
transmission. Glutamate is the principal excitatory neurotrans-
mitter in the CNS. Glutamate release from presynaptic nerve
terminals activates post-synaptic glutamate receptors including
NMDA, AMPA, and Kainate receptors (Fykse and Fonnum,
1996). However, overactivation of glutamate receptors can be
neurotoxic, a process termed excitotoxicity (Olney et al., 1972).
Excitotoxic neuronal cell death is primarily mediated by exces-
sive Ca2+ influx via NMDA receptors (Choi, 1985, 1987, 1988)
and has been implicated in neurological disorders including
stroke, traumatic brain injury, ischemia, Huntington’s disease
and amyotrophic lateral sclerosis (Dirnagl et al., 1999; Waggie
et al., 1999; Mehta et al., 2013). Glutamate neurotoxicity but also
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other processes such as ischemia/reperfusion injury also invoke
oxidative stress (Barnham et al., 2004).
Recent studies have shown that excitotoxic and oxidative
stress-induced neuronal injury involves BCL-2 family proteins.
Specifically, injury conditions that produce a more delayed neu-
ronal injury are often triggered by the transcriptional and post-
translational activation of BH-3 only proteins such as BIM,
PUMA, and BID (Konig et al., 2007; Steckley et al., 2007;
Concannon et al., 2010). Similarly, the pro-apoptotic BAX pro-
tein has been shown to be implicated in excitotoxicity, oxidative
stress and trophic factor deprivation-induced neuronal apopto-
sis (Deckwerth et al., 1996; D’Orsi et al., 2012). In this review
we focus on recent advancements in describing the role of indi-
vidual anti-apoptotic BCL-2 family proteins during neuronal
development, injury and neurodegeneration.
BCL-2
BCL-2 is widely expressed in the developing brain including,
neuroepithelial cells of the ventricular zones as well as the post-
mitotic cells of the cortical plate, cerebellum, hippocampus and
spinal cord (Merry et al., 1994). BCL-2 knockout mice show nor-
mal embryonic development but present with lymphoid apopto-
sis, neuronal and intestinal lesions and terminal kidney disease
(Veis et al., 1993). High expression of BCL-2mRNA was observed
in the developing nervous system and reduced significantly in the
post-natal brain (Abe-Dohmae et al., 1993; Merry et al., 1994).
Interestingly, high level of BCL-2 expression was maintained in
sensory and sympathetic adult neurons (Merry et al., 1994). BCL-
2 acts as an important regulator of cell death in developing
sympathetic neurons after neuronal growth factor deprivation,
whereas BCL-2 is not involved in the survival of mature sym-
pathetic neurons (Greenlund et al., 1995). Overexpression of
BCL-2 inhibited BAX-mediated cytochrome-c release, caspase
activation and cell death in nerve growth factor-deprived sympa-
thetic neurons (Putcha et al., 1999). These results taken together
indicate that BCL-2 plays an important role specifically during
development of the nervous system.
Functional studies in primary neuron cultures and animal
models indicated that BCL-2 overexpression protected hip-
pocampal neurons against glutamate-mediated excitotoxicity,
and significantly reduced lesion size in the hippocampus result-
ing from NMDA induced excitotoxic damage (Wong et al.,
2005). Overexpression of BCL-2 blocked translocation of apop-
tosis inducing factor (AIF) from mitochondria to the nucleus,
resulting in improved cortical neuron survival following focal
cerebral ischemia (Zhao et al., 2004). BCL-2 deficient mice show
enhanced oxidative stress and alterations in antioxidants in the
brain (Hochman et al., 1998) and up-regulation of BCL-2 may
aid DNA repair following oxidative stress (Deng et al., 1999).
Interestingly, BCL-2 expression also inhibited apoptosis of new-
born neurons following MCAO in adult rat brains (Zhang et al.,
2006). Transgenic mice overexpressing BCL-2 in neurons resulted
in hypertrophy of the nervous system caused by reduced natu-
rally occurring cell death but also showed a 50% reduction in
brain infarct volume compared to wild type mice after permanent
ischemia induced byMCAO(Martinou et al., 1994). Furthermore,
transplantation of embryonic stem cells overexpressing BCL-2
into the post-infarct brain cavity of adult rats after MCAO
resulted in neuronal differentiation and improvements in func-
tional recovery and behavioral testing (Wei et al., 2005). Of note,
alterations in endoplasmic reticulumCa2+ homeostasis have been
shown to induce apoptosis in neurons (Mattson et al., 2000).
BCL-2 also modulates ER Ca2+ content by decreasing ER Ca2+
uptake (Ferrari et al., 2002; Rudner et al., 2002) which supports
axon regeneration and neurite outgrowth during energy stress
and mobilizes intracellular calcium signaling (Jiao et al., 2005).
These results suggest that BCL-2 may represent an interesting
target in stroke recovery therapy.
BCL-XL
The BCL-X gene can be alternatively spliced to produce two
protein isoforms, BCL-XL and BCL-XS (Gonzalez-Garcia et al.,
1994). BCL-XL acts as an anti-apoptotic protein whereas BCL-Xs
exhibits pro-apoptotic properties. BCL-XL is found in post-
mitotic cells in the adult brain whereas BCL-XS expression is
predominantly expressed in developing cells with a high turnover
rate such as lymphocytes (Boise et al., 1993). BCL-XL is highly
expressed in developing neurons as they migrate away from ven-
tricular zone, and remains up-regulated in post-mitotic neurons
in the adult brain (Motoyama et al., 1995; Roth et al., 2000).
BCL-XL shows close homology to BCL-2 (Gonzalez-Garcia et al.,
1994). Deletion of BCL-X induces massive apoptotic cell death in
developing neurons throughout the nervous system and results
in lethality at embryonic day 13 (Motoyama et al., 1995; Akhtar
et al., 2004). BCL-XL also protects cultured sympathetic neurons
against nerve growth factor withdrawal (Gonzalez-Garcia et al.,
1995). These data suggest that BCL-XL plays important roles dur-
ing development of the nervous system; in addition BCL- XL is
also expressed at high levels in the adult nervous system.
Overexpression of BCL-XL protected neurons in the hip-
pocampus and cortex against hypoxic-ischemia (Parsadanian
et al., 1998). Systemic delivery of BCL-XL fusion protein inhib-
ited caspase-3 and -9 activities and also prevented translocation
of AIF into the nucleus following hypoxic-ischemic brain injury
(Yin et al., 2006). Interestingly, ischemic preconditioning blocked
the assembly of BAD with BCL-XL, cleavage of BCL-XL to a
pro-apoptotic form, and release of pro-apoptotic factors from
mitochondria (Miyawaki et al., 2008). Overexpression of BCL-XL
also protected primary rat septal neurons against oxygen glu-
cose deprivation and hypoglycaemic stress (Panickar et al., 2005).
Furthermore, decreased expression of BCL-XL has been impli-
cated in spinal cord injury induced neuronal cell death. This
was attenuated by exogenous administration of a BCL-XL fusion
protein into the spinal cord (Nesic-Taylor et al., 2005). In addi-
tion, transplantation of neural stem cells overexpressing BCL-XL
enhanced graft survival by supplying tropic factors essential for
survival, and improved locomotor recovery in rats following
spinal cord injury (Lee et al., 2009).
BCL-XL is also involved in non-apoptotic processes such as
synapse formation. Overexpression of BCL-XL in hippocampal
neurons increased synapse numbers and localization of mito-
chondria to synapses, a process that was modulated through the
mitochondrial fission protein, dynamin related protein 1 (Li et al.,
2008). Interestingly, BCL-XL demonstrated a dual role in synaptic
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transmission under hypoxia (Hickman et al., 2008). Inhibition of
BCL-XL resulted in reduced recovery of synaptic responses under
hypoxia, but exerted neuroprotective effect (Hickman et al.,
2008). Recently, it has been demonstrated that BCL-XL is impor-
tant in maintaining mitochondrial fission, fusion and biomass
(Berman et al., 2009), and directly interacts with ATP synthase
to stabilize the mitochondrial membrane potential (Chen et al.,
2011). BCL-XL has also been demonstrated to influence Ca2+
signaling in astrocytes induced by the activation of inositol 1,4,5-
triphosphate (IP3)-generating metabotropic type 5 glutamate
receptors (mGluR5) during the process of motoneuron degenera-
tion. Administration of the BH4 domain of BCL-X(L) fused to the
protein transduction domain of the HIV-1 TAT protein was suf-
ficient to restore Ca2+ homeostasis in astrocytes overexpressing
the ALS-associated SOD1 (G93A) mutation, and chronic treat-
ment of SOD1(G93A) transgenic mice with the TAT-BH4 peptide
delayed the onset of the disease and improvedmotor function and
lifespan (Martorana et al., 2012).
BCL-w
BCL-w also known as BCL2-like 2 (Bcl2l2) is a highly conserved
gene located on the mouse chromosome 14 and the human
chromosome 14 at band q11. BCL-w is highly expressed partic-
ularly in the brain, colon and testes and is also associated with
Table 1 | Non-cell death related functions of anti-apoptotic proteins.
Anti-apoptotic proteins Physiological state
BCL-2 Regulates ER Ca2+ homeostasis by
decreasing the ER Ca2+ uptake (Ferrari et al.,
2002; Rudner et al., 2002)
Supports axon regeneration and neurite
outgrowth (Jiao et al., 2005)
BCL-XL Involved in synapse formation
Increases synapse number and localization of
mitochondria to synapse (Hickman et al., 2008)
Maintains mitochondrial fusion, fission, and
biomass (Berman et al., 2009)
Stabilizes mitochondrial membrane potential
by directly interacting with ATP synthase
(Chen et al., 2011)
Stabilizes IP3-receptor mediated Ca2+
signaling in astrocytes (Martorana et al., 2012)
BCL-w Regulates neuronal excitability by modulating
GABA-mediated currents (Murphy et al., 2007)
MCL-1 Localizes on mitochondrial outer membrane
and inner membrane. Antagonizes
anti-apoptotic proteins and maintains normal
mitochondrial bioenergetics status (Perciavalle
et al., 2012)
Regulates mitochondrial fusion, fission, and
cristae formation and facilitates ATP
production (Perciavalle et al., 2012)
Maintains cystosolic Ca2+ homeostasis and
increases mitochondrial membrane potential
(Anilkumar et al., 2013)
intracellular membranes (O’Reilly et al., 2001). Although BCL-w
is widely expressed, mice deficient in BCL-w failed to show large
abnormalities with the exception of increased apoptosis in sperm
cells during spermatogenesis, resulting in a sterile male pheno-
type (Print et al., 1998). The level of BCL-w has been shown to
increase during neuronal development and BCL-w has been local-
ized to specific regions of the mature brain where it may play
a crucial role in maintaining their neuronal survival (Hamner
et al., 1999). In this context, BCL-w overexpression increased
neuronal survival in NGF-dependent trigerminal neurons and
BDNF- dependent nodose neurons over the period of develop-
ment in response to neurotrophin withdrawal (Middleton et al.,
2001).
Functional studies revealed that BCL-w interacts with the pro-
apoptotic protein BAD and blocks neuronal death induced by
growth factor deprivation in sympathetic neurons (Hamner et al.,
2001). Interestingly, BCL-w expression was found to be increased
in mouse neurons up to 72 h after transient middle cerebral
artery occlusion (MCAO). Moreover, BCL-w co-localized with
mitochondria in non-fragmented neurons and protected neurons
against Ca2+ mediated brain injury by inhibiting cytochrome-c
release and maintaining mitochondrial membrane potential fol-
lowing MCAO (Yan et al., 2000). Mouse deficient in BCL-w
showed an increased neuronal loss and nuclear fragmentation
in the hippocampus after status epilepticus with a neurophysi-
ological phenotype leading to earlier onset of seizure, and was
suggested to influence neuronal excitability (Murphy et al., 2007).
This effect may be regulated through an effect of BCL-w on
GABA-mediated currents, a disruption of which may lead to
seizure induction (Murphy et al., 2007). Furthermore, in an
experimental model of Alzheimer’s disease, BCL-w blocked the
mitochondrial release of Smac and inhibited neuronal apopto-
sis induced by β-amyloid (Yao et al., 2005). Using a rat model
of transient MCAO and oxygen glucose deprivation in neurons,
it was demonstrated that BCL-w plays an important role in neu-
roprotection following ischemic injury and is directly regulated
by microRNA-29b (Shi et al., 2012). There results taken together
suggest that BCL-w plays an important role in various neurolog-
ical conditions to protect neurons and therefore also presents an
attractive target to development of therapeutic agents.
MCL-1
The human MCL-1 gene is located on chromosome 1q21, and
MCL-1 proteins were originally isolated from myeloid leukemia
cells (Kozopas et al., 1993). MCL-1 is prominently expressed in
neuroendocrine cells, sympathetic neurons, cardiac and skeletal
muscles (Krajewski et al., 1995). Importantly, diffuse expres-
sion and rapid induction of transcription of MCL-1 is found
in neurons (Mori et al., 2004). MCL-1 germline deletion in
mice resulted in peri-implantation lethality at embryonic day 3.5,
showing the most severe phenotype amongst the anti-apoptotic
BCL-2 family members (Rinkenberger et al., 2000). MCL-1 is
associated with membranes through its C-terminal hydropho-
bic tail and has a predominant mitochondrial localization (Yang
et al., 1995). Recently, it has been demonstrated that MCL-1
is spliced into two variants and resides in two distinct mito-
chondrial regions: outer membrane (MCL-1OM) and matrix
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(MCL-1MATRIX), and has been proposed to exert differential
effects depending on its location: MCL-1OM antagonizes apopto-
sis, whereas MCL-1MATRIX facilitates ATP production, membrane
potential, respiration, cristae ultrastructure and mitochondrial
fusion (Perciavalle et al., 2012).
MCL-1 is essential for neuronal development. Conditional
deletion of MCL-1 in mice induced apoptosis of neuronal pro-
genitors and newly committed neurons as they commence their
migration away from the ventricular zone (Arbour et al., 2008).
In addition, conditional deletion of MCL-1 in vitro in neuronal
precursor cells showed a two-fold increase in apoptosis (Malone
et al., 2012). These results suggested that MCL-1 is crucial for
survival of neuronal precursor cells. Recently, it has been demon-
strated that MCL-1 can act as a switch between autophagy and
apoptosis in a developmentally regulated manner under energetic
stress conditions (Germain et al., 2011). Being an anti-apoptotic
BCL-2 family member, MCL-1 inhibited apoptosis by binding
and sequestering the pro-apoptotic BCL-2 family member BAK
(Willis et al., 2005) and blocking the activation and transloca-
tion of BAX (Chen et al., 2007). Interestingly, MCL-1 protected
cortical neurons against NMDA-mediated excitotoxicity, but also
increased mitochondrial bioenergetics of cortical neurons and
normalized neuronal Ca2+ homeostasis during NMDA excita-
tion (Anilkumar et al., 2013). Such dual effects of MCL-1 may
make it an attractive target for the treatment of neurodegenerative
disorders such as Alzheimer’s and Parkinson’s disease, in which
altered bioenergetics and increased neuronal loss are so promi-
nent. MCL-1 heterozygous mice also demonstrated increased
neuronal sensitivitiy against pilocarpine-induced status epilep-
ticus (Mori et al., 2004). Furthermore, sustained expression of
MCL-1 protected and loss of MCL-1 increased DNA damage-
induced neuron death (Arbour et al., 2008). A recent study has
also shown that apoptosis induced by serum and KCl deprivation
in cerebellar granule neuron was mediated by proteasomal degra-
dation of MCL-1, and that stabilization of MCL-1 by blocking
its ubiquitination and degradation was protective (Magiera et al.,
2013). In addition, neurons depleted of Parkin, mutated gene in
juvenile onset and familial forms of Parkinson’s disease, became
acutely sensitive to oxidative stress, and this was attributed to
decreased MCL-1 levels (Ekholm-Reed et al., 2013). Although
the role of MCL-1 in neurons and neurodegenrative disorders
warrants further investigation, emerging evidence suggests that it
may represent the most promising therapeutic target of all BCL-2
family proteins studied so far.
CONCLUSION
BCL-2 family proteins have been firmly established to play a sig-
nificant role in initiating or inhibiting apoptosis during neuronal
development and injury. Emerging evidence suggests that some of
the anti-apoptotic protein family members are involved in main-
taining both mitochondrial bioenergetics and neuronal survival,
in particular BCL-XL and MCL-1. BCL-2, BCL-XL and MCL-1
modulation of Ca2+ signaling during acute neuronal injury may
also play a vital role in neuroprotection. Hence manipulating the
pro-survival BCL-2 family members may be beneficial in devel-
oping future therapies for neurological and neurodegenerative
disorders. In addition, exploiting neural stem cells overexpressing
anti-apoptotic BCL-2 family proteins may provide an attractive
and powerful tool for post-neuronal injury therapies.
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